Literature DB >> 33148708

Despite Excellent Test Characteristics of the cobas 4800 CT/NG Assay, Detection of Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Remains Challenging.

J M van Niekerk1, B M J W van der Veer1, C J P A Hoebe2, J van de Bovenkamp3, C van Herk3, I H M van Loo1, L B van Alphen1, P F G Wolffs4.   

Abstract

Oropharyngeal Chlamydia trachomatis (CT) infections and, especially, Neisseria gonorrhoeae (NG) infections are common, but few commercial nucleic acid amplification tests (NAATs) specify extragenital samples for intended use. The test characteristics of the cobas 4800 CT/NG assay were evaluated for oropharyngeal swabs. The technical validation included analysis of the specificity, sensitivity, dynamic range, linearity, efficiency, and precision. The probability of detection curve combined with historical data enabled the estimation of potentially missed diagnoses. A clinical evaluation was performed on a subset of 2,798 clinical samples available from routine diagnostics. Results of the cobas 4800 were compared with those from in-house C. trachomatis/N. gonorrhoeae PCR assays. Discrepant samples were tested with resolver assays, and these results were considered decisive. No cross-reactivity was seen in the analytical specificity analysis. High linearity (R 2 ≥ 0.983), efficiency (89% to 99%), and precision (cycle threshold [CT ] value of 0.1 to 0.9) were seen for both C. trachomatis and N. gonorrhoeae The limit of detection in oropharyngeal samples was 3.2 × 102 inclusion-forming units (IFU)/ml for C. trachomatis and 6.7 × 102 CFU/ml for N. gonorrhoeae Estimates on potentially missed diagnoses were up to 7.2% for C. trachomatis and up to 24.7% for N. gonorrhoeae Clinical sensitivity and specificity were evaluated with 25 C. trachomatis-positive, 86 N. gonorrhoeae-positive, and 264 negative samples, resulting in 100% and 99.6% for C. trachomatis and 100% and 96.7% for N. gonorrhoeae, respectively. The findings in this study demonstrate the utility of the cobas 4800 CT/NG assay for oropharyngeal samples. Despite its being a highly accurate test, the range of reported CT values, especially for N. gonorrhoeae, suggests relatively low oropharyngeal loads. Hence, consistent detection over the full range of oropharyngeal loads could be impaired.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  Chlamydia trachomatiszzm321990; NAAT; Neisseria gonorrhoeaezzm321990; cobas; evaluation; extragenital; limit of detection; oropharyngeal; probability of detection; validation

Year:  2021        PMID: 33148708      PMCID: PMC8111131          DOI: 10.1128/JCM.02137-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Screening tests for Chlamydia trachomatis or Neisseria gonorrhoeae using the cobas 4800 PCR system do not require a second test to confirm: an audit of patients issued with equivocal results at a sexual health clinic in the Northwest of England, U.K.

Authors:  Mark J Hopkins; Godfrey Smith; Ian J Hart; Fath Alloba
Journal:  Sex Transm Infect       Date:  2012-06-01       Impact factor: 3.519

2.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

Authors:  Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer
Journal:  Clin Chem       Date:  2009-02-26       Impact factor: 8.327

3.  Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens.

Authors:  Manuel Parra-Sánchez; Jose Carlos Palomares; Samuel Bernal; María Trinidad González; Nieves Sivianes; Luis Pérez; Isabel Pueyo; Estrella Martín-Mazuelos
Journal:  Diagn Microbiol Infect Dis       Date:  2012-09-17       Impact factor: 2.803

4.  Validation of a laboratory-developed real-time PCR protocol for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine.

Authors:  M J Hopkins; L J Ashton; F Alloba; A Alawattegama; I J Hart
Journal:  Sex Transm Infect       Date:  2010-06       Impact factor: 3.519

5.  Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2014-03-14

6.  Evaluation of the specificities of five DNA amplification methods for the detection of Neisseria gonorrhoeae.

Authors:  H M Palmer; H Mallinson; R L Wood; A J Herring
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Men and Women Have Similar Neisseria gonorrhoeae Bacterial Loads: a Comparison of Three Anatomical Sites.

Authors:  Brian M J W van der Veer; Christian J P A Hoebe; Nicole H T M Dukers-Muijrers; Lieke B van Alphen; Petra F G Wolffs
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

8.  Men and Women Have an Equal Oropharyngeal and Anorectal Chlamydia trachomatis Bacterial Load: A Comparison of 3 Anatomic Sites.

Authors:  Juliën N A P Wijers; Nicole H T M Dukers-Muijrers; Geneviève A F S van Liere; Jeanne A M C Dirks; Petra F G Wolffs; Christian J P A Hoebe
Journal:  J Infect Dis       Date:  2021-05-20       Impact factor: 5.226

9.  Culture-free genotyping of Neisseria gonorrhoeae revealed distinct strains at different anatomical sites in a quarter of patients, the Netherlands, 2012 to 2016.

Authors:  Brian Mjw van der Veer; Petra Fg Wolffs; Christian Jpa Hoebe; Nicole Htm Dukers-Muijrers; Lieke B van Alphen
Journal:  Euro Surveill       Date:  2018-12

10.  Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016.

Authors:  Jane Rowley; Stephen Vander Hoorn; Eline Korenromp; Nicola Low; Magnus Unemo; Laith J Abu-Raddad; R Matthew Chico; Alex Smolak; Lori Newman; Sami Gottlieb; Soe Soe Thwin; Nathalie Broutet; Melanie M Taylor
Journal:  Bull World Health Organ       Date:  2019-06-06       Impact factor: 9.408

View more
  1 in total

1.  Fluorescent Biosensor Based on Hairpin DNA Stabilized Copper Nanoclusters for Chlamydia trachomatis Detection.

Authors:  Luyao Liu; Qinqin Bai; Xuebing Zhang; Chunxue Lu; Zhongyu Li; Hao Liang; Lili Chen
Journal:  J Fluoresc       Date:  2022-05-25       Impact factor: 2.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.